Aim: To synthesize and evaluate a novel curcumin-cobalt complex to enhance curcumin__ampersandsignrsquo;s stability, solubility, and pharmacokinetics, thereby overcoming its limitations in clinical applications. Methodology: The curcumin-cobalt complex was synthesized and subjected to theoretical investigations using molecular docking and density functional theory (DFT) to analyze binding interactions and electronic properties. In silico ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was conducted using various software tools to assess the complex__ampersandsignrsquo;s pharmacokinetic profile and safety. Results: The curcumin-cobalt complex demonstrated improved stability and solubility compared to curcumin alone. Molecular docking and DFT studies revealed strong binding interactions and favorable electronic properties. In silico ADMET analysis indicated enhanced pharmacokinetic parameters, including better absorption and distribution, along with low toxicity potential. These findings suggest the complex as a promising candidate for therapeutic use with reduced metabolic limitations. Conclusion: The curcumin-cobalt complex successfully addresses curcumin__ampersandsignrsquo;s bioavailability and stability issues, offering enhanced pharmacokinetic properties and a favorable safety profile. This research highlights the potential of metal complexation to optimize curcumin__ampersandsignrsquo;s therapeutic efficacy. Future in vivo studies are necessary to validate these results and explore the complex__ampersandsignrsquo;s potential in managing chronic diseases, expanding curcumin__ampersandsignrsquo;s therapeutic applications.